Skip to main content

Advertisement

Log in

Fruit and vegetable intake and bone health in women aged 45 years and over: a systematic review

  • Review
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

High fruit and vegetable intake may be associated with improved bone status among women aged ≥45 years. This is the first systematic review that specifically assessed this association and identified research gaps. The benefits of fruit and vegetables (F&V) on bone health remain unclear. Further studies are needed.

Introduction

F&V have several components that are beneficial to bones. Some studies report that high F&V intake is associated with improved bone status in middle aged and aged women; however, findings are inconsistent. The objective was to systematically review observational and interventional studies that investigated the effects of F&V intake on incidence of osteoporotic fractures, bone mineral density (BMD), and bone turnover markers (BTM) in women aged ≥45 years and to identify potential research gaps.

Methods

Electronic databases were searched, and peer-reviewed manuscripts published in English, with F&V intake as a main dietary exposure, were included. Data selection, extraction, and evaluation of risk of bias were performed independently by two reviewers.

Results

Eight studies were included. One cohort study reported cross-sectional as well as longitudinal data. There was significant between-study heterogeneity in design, definition, and amount of F&V intake, outcomes, analyses, and reporting of results. Two studies had low, two had moderate, and four had high risk of bias. Among reports with low or moderate risk of bias, two cross-sectional analyses reported positive associations between F&V intake and BMD of the forearm, lumbar spine, or total hip, whereas one randomized controlled trial and two prospective cohort analyses reported no effects. One trial reported no associations between F&V and BTM.

Conclusions

Based on limited evidence, the benefits of F&V on bone health remain unclear for women aged ≥45 years. Further studies with low risk of bias are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Johnell O, Kanis JA (2004) An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int 15:897–902

    Article  PubMed  CAS  Google Scholar 

  2. National Osteoporosis Foundation (2010) Osteoporosis prevalence: gender. National Osteoporosis Foundation. Available at: http://www.nof.org/osteoporosis/diseasefacts.htm. Accessed on: September 2010

  3. Delaney MF (2006) Strategies for the prevention and treatment of osteoporosis during early postmenopause. Am J Obstet Gynecol 194:S12–S23

    Article  PubMed  Google Scholar 

  4. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 7:390–406

    Article  PubMed  CAS  Google Scholar 

  5. McCombs JS, Thiebaud P, Laughlin-Miley C, Shi J (2004) Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 48:271–287

    Article  PubMed  CAS  Google Scholar 

  6. Weycker D, Macarios D, Edelsberg J, Oster G (2006) Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 17:1645–1652

    Article  PubMed  CAS  Google Scholar 

  7. Imaz I, Zegarra P, Gonzalez-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 11:1943–1951

    Article  Google Scholar 

  8. Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216

    Article  PubMed  Google Scholar 

  9. Trzeciakiewicz A, Habauzit V, Horcajada MN (2009) When nutrition interacts with osteoblast function: molecular mechanisms of polyphenols. Nutr Res Rev 22:68–81

    Article  PubMed  CAS  Google Scholar 

  10. Mundy GR (2006) Nutritional modulators of bone remodeling during aging. Am J Clin Nutr 83:427S–430S

    PubMed  CAS  Google Scholar 

  11. Tucker KL (2009) Osteoporosis prevention and nutrition. Curr Osteoporos Rep 7:111–117

    Article  PubMed  Google Scholar 

  12. Morgan KT (2008) Nutritional determinants of bone health. J Nutr Elder 27:3–27

    Article  PubMed  Google Scholar 

  13. Cashman KD (2007) Diet, nutrition, and bone health. J Nutr 137:2507S–2512S

    PubMed  CAS  Google Scholar 

  14. Heaney RP (2009) Dairy and bone health. J Am Coll Nutr 28(Suppl 1):82S–90S

    PubMed  CAS  Google Scholar 

  15. Kitchin B, Morgan SL (2007) Not just calcium and vitamin D: other nutritional considerations in osteoporosis. Curr Rheumatol Rep 9:85–92

    Article  PubMed  CAS  Google Scholar 

  16. Lister CE, Skinner MA, Hunter DC (2007) Fruits, vegetables and their phytochemicals for bone and joint health. Curr Top Nutraceutical Res 5:67–82

    CAS  Google Scholar 

  17. Macdonald HM (2007) Influence of organic salts of potassium on bone health: possible mechanisms of action for the role of fruit and vegetables. Int Congr Ser 1297:268–281

    Article  CAS  Google Scholar 

  18. Lanham-New SA (2006) Fruit and vegetables: the unexpected natural answer to the question of osteoporosis prevention? Am J Clin Nutr 83:1254–1255

    PubMed  CAS  Google Scholar 

  19. New SA (2003) Intake of fruit and vegetables: implications for bone health. Proc Nutr Soc 62:889–899

    PubMed  Google Scholar 

  20. Buclin T, Cosma M, Appenzeller M, Jacquet AF, Decosterd LA, Biollaz J, Burckhardt P (2001) Diet acids and alkalis influence calcium retention in bone. Osteoporos Int 12:493–499

    Article  PubMed  CAS  Google Scholar 

  21. Arnett TR (2008) Extracellular pH regulates bone cell function. J Nutr 138:415S–418S

    PubMed  CAS  Google Scholar 

  22. Brandao-Burch A, Utting JC, Orriss IR, Arnett TR (2005) Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Calcif Tissue Int 77:167–174

    Article  PubMed  CAS  Google Scholar 

  23. Hunter DC, Skinner MA, Lister CE (2008) Impact of phytochemicals on maintaining bone and joint health. Nutrition 24:390–392

    Article  PubMed  CAS  Google Scholar 

  24. Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167:S1–S34

    PubMed  Google Scholar 

  25. Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. Rev Lat Am Enferm 288:1889–1897

    Google Scholar 

  26. ISCD The International Society for Clinical Densitometry (ISCD). The 2007 Official Position of ISCD: Indications for Bone Mineral Density (BMD) testing. The International Society for Clinical Densitometry (ISCD) Website. Available at: http://www.iscd.org/visitors/positions/OfficialPositionsText.cfm. Accessed on: September 2010

  27. Nikander R, Sievanen H, Heinonen A, Daly RM, Uusi-Rasi K, Kannus P (2010) Targeted exercise against osteoporosis: a systematic review and meta-analysis for optimising bone strength throughout life. BMC Med 8:47

    Article  PubMed  Google Scholar 

  28. Civitelli R, Rmamento-Villareal R, Napoli N (2009) Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int 20:843–851

    Article  PubMed  CAS  Google Scholar 

  29. Eastell R, Hannon RA (2008) Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc 67:157–162

    Article  PubMed  Google Scholar 

  30. Balk EM, Horsley TA, Newberry SJ, Lichtenstein AH, Yetley EA, Schachter HM, Moher D, MacLean CH, Lau J (2007) A collaborative effort to apply the evidence-based review process to the field of nutrition: challenges, benefits, and lessons learned. Am J Clin Nutr 85:1448–1456

    PubMed  CAS  Google Scholar 

  31. Chung M, Balk EM, Ip S, Raman G, Yu WW, Trikalinos TA, Lichtenstein AH, Yetley EA, Lau J (2009) Reporting of systematic reviews of micronutrients and health: a critical appraisal. Am J Clin Nutr 89:1099–1113

    Article  PubMed  CAS  Google Scholar 

  32. Lichtenstein AH, Yetley EA, Lau J (2008) Application of systematic review methodology to the field of nutrition. J Nutr 138:2297–2306

    Article  PubMed  CAS  Google Scholar 

  33. The Cochrane Collaboration (2009) Cochrane handbook for systematic reviews of interventions-version 5.0.2. The Cochrane Collaboration. Available at: http://www.cochrane-handbook.org/. Accessed on: September 2010

  34. Macdonald HM, Black AJ, Aucott L, Duthie G, Duthie S, Sandison R, Hardcastle AC, Lanham New SA, Fraser WD, Reid DM (2008) Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial. Am J Clin Nutr 88:465–474

    PubMed  CAS  Google Scholar 

  35. Ebrahimof S, Hoshiarrad A, Hossein-Nezhad A, Larijani B, Kimiagar SM (2009) Effects of increasing fruit and vegetable intake on bone turnover in postmenopausal osteopenic women. Daru 17:30–37

    Google Scholar 

  36. Ebrahimof S, Hoshyarrad A, Hossein-Nezhad A, Zandi N, Larijani B, Kimiagar M (2006) Fruit and vegetable intake in postmenopausal women with osteopenia. Arya J 1:183–187

    Google Scholar 

  37. Chen YM, Ho SC, Woo JL (2006) Greater fruit and vegetable intake is associated with increased bone mass among postmenopausal Chinese women. Br J Nutr 96:745–751

    Article  PubMed  CAS  Google Scholar 

  38. Prynne CJ, Mishra GD, O’Connell MA, Muniz G, Laskey MA, Yan L, Prentice A, Ginty F (2006) Fruit and vegetable intakes and bone mineral status: a cross sectional study in 5 age and sex cohorts. Am J Clin Nutr 83:1420–1428

    PubMed  CAS  Google Scholar 

  39. Kaptoge S (2003) Effects of dietary nutrients and food groups on bone loss from the proximal femur in men and women in the 7th and 8th decades of age. Osteoporos Int 14:5–428

    Article  Google Scholar 

  40. Xu L, Dibley M, D’Este C, Phillips M, Porteous J, Attia J (2009) Food groups and risk of forearm fractures in postmenopausal women in Chengdu, China. Climacteric 2:222–229

    Article  Google Scholar 

  41. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP (1999) Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 69:727–736

    PubMed  CAS  Google Scholar 

  42. Tucker KL, Chen H, Hannan MT, Cupples LA, Wilson PW, Felson D, Kiel DP (2002) Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 76:245–252

    PubMed  CAS  Google Scholar 

  43. Tucker KL (2003) Dietary intake and bone status with aging. Curr Pharm Des 9:2687–2704

    Article  PubMed  CAS  Google Scholar 

  44. Weaver CM (2009) Should dairy be recommended as part of a healthy vegetarian diet? Point. Am J Clin Nutr 89:1634S–1637S

    Article  PubMed  CAS  Google Scholar 

  45. Lin PH, Aickin M, Champagne C, Craddick S, Sacks FM, McCarron P, Most-Windhauser MM, Rukenbrod F, Haworth L (2003) Food group sources of nutrients in the dietary patterns of the DASH-Sodium Trial. J Am Diet Assoc 103:488–496

    Article  PubMed  Google Scholar 

  46. Kontogianni MD, Melistas L, Yannakoulia M, Malagaris I, Panagiotakos DB, Yiannakouris N (2009) Association between dietary patterns and indices of bone mass in a sample of Mediterranean women. Nutrition 25:165–171

    Article  PubMed  Google Scholar 

  47. Mendoza Ladron De Guevara N, Santalla A, Moron F, Astorquina TM, Gonzalez A, Quereda F, Criado MSL, Vazquez F, Borrego RS, Ruiz A (2008) Epidemiological characteristics of a population of postmenopausal women with osteopenia and osteoporosis: importance of the Mediterranean diet. Prog Obstet Ginecol 51:265–270

    Article  Google Scholar 

  48. World Health Organization (2003) Diet, nutrition and the prevention of chronic diseases-recommendations for preventing osteoporosis-disease-specific recommendations. World Health Organization. Available at: http://www.fao.org/DOCREP/005/AC911E/ac911e07.htm#bm07.7. Accessed on: September 2010

  49. International Osteoporosis Foundation (2009) Facts and statistics about osteoporosis and its impact-nutrition. International Osteoporosis Foundation. Available at: http://www.iofbonehealth.org/facts-and-statistics.html#factsheet-category-21. Accessed on: September 2010

  50. Fulgoni VL III, Huth PJ, DiRienzo DB, Miller GD (2004) Determination of the optimal number of dairy servings to ensure a low prevalence of inadequate calcium intake in Americans. J Am Coll Nutr 23:651–659

    PubMed  CAS  Google Scholar 

  51. Nicklas TA, O’Neil CE, Fulgoni VL III (2009) The role of dairy in meeting the recommendations for shortfall nutrients in the American diet. J Am Coll Nutr 28(Suppl 1):73S–81S

    PubMed  CAS  Google Scholar 

  52. Agudo A (2004) Measuring intake of fruit and vegetables. World Health Organization (WHO). Available at: http://www.who.int/dietphysicalactivity/fruit/en/. Accessed on: September 2010

  53. Pomerleau J, Lock K, McKee M, Altmann DR (2004) The challenge of measuring global fruit and vegetable intake. J Nutr 134:1175–1180

    PubMed  CAS  Google Scholar 

  54. Reedy J, Haines PS, Campbell MK (2005) Differences in fruit and vegetable intake among categories of dietary supplement users. J Am Diet Assoc 105:1749–1756

    Article  PubMed  Google Scholar 

  55. Trudeau E, Kristal AR, Li S, Patterson RE (1998) Demographic and psychosocial predictors of fruit and vegetable intakes differ: implications for dietary interventions. J Am Diet Assoc 98:1412–1417

    Article  PubMed  CAS  Google Scholar 

  56. Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, Colditz GA, Rosner B, Spiegelman D, Willett WC (2004) Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96:1577–1584

    Article  PubMed  Google Scholar 

  57. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663–694

    PubMed  CAS  Google Scholar 

  58. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457

    Article  Google Scholar 

  59. He FJ, Nowson CA, MacGregor GA (2006) Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 367:320–326

    Article  PubMed  Google Scholar 

  60. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269

    PubMed  Google Scholar 

Download references

Acknowledgments

We sincerely thank Ms. Elizabeth Uleryk for her assistance in developing and executing the search strategy as well as Dr. Kyarash Safakish (MD) for his review of excluded citations based on titles and abstracts to ensure all citations met the exclusion criteria.

Contributions

MH was involved in project conception, development of review protocol, and study oversight and wrote the initial draft. BAB, PSS, and AMC, respectively, were all involved in the design and execution of the review and made substantial revisions to the manuscript. AMC provided advice and interpreted findings on bone health, BAB on nutrition, and PSS, JB, and AMC on conducting systematic reviews and meta-analysis. MH and PSS reviewed the selected full-text articles and determined the risk of bias independently. BAB reviewed the selected articles and extracted data to ensure information was complete. The risk of bias tool was designed by PSS and modified by MH for studies in the field of nutrition and bone health. All authors commented on and approved the final manuscript. AMC has primary responsibility for final content.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. M. Cheung.

Appendices

Appendix A: search strategy

MEDLINE

exp “Bone and Bones”/or bone mineral density.mp. or (bone mineral density) .ti,ab. or exp Bone Density/or bone remodeling/or bone regeneration/or bone resorption/or (Biological Markers/and “Bone and Bones”/) or exp Osteoporosis, Postmenopausal/or exp Osteoporosis/or exp Fractures, Bone/or (bone adj2 turnover).ti,ab. or (bone adj2 marker*).ti,ab. or (bone adj2 biomarker*).ti,ab. or (bone adj2 formation).ti,ab.

exp fruit/or exp vegetables/or (Fruit* and Vegetable*).mp. or fruit*.mp. or vegetable*.mp. or (fruit* adj2 vegetable*).ti,ab.

(clinical trial, all or clinical trial, phase I or clinical trial, phase II or clinical trial, phase III or clinical trial, phase IV or clinical trial or controlled clinical trial or meta-analysis or multicenter study or randomized controlled trial).pt. or exp Clinical Trials as Topic/or exp cross-sectional studies/or exp clinical trial/or exp clinical trials as topic/or exp clinical trials, phase I as topic/or exp clinical trials, phase II as topic/or exp clinical trials, phase III as topic/or exp clinical trials, phase IV as topic/or exp controlled clinical trials as topic/or exp randomized controlled trials as topic/or exp multicenter studies as topic/or exp intervention studies/or exp twin studies as topic/or epidemiologic studies/or exp study characteristics/or exp epidemiologic study characteristics as topic/or exp epidemiologic research design/or exp case-control studies/or exp retrospective studies/or exp cohort studies/or exp longitudinal studies/or exp follow-up studies/or exp prospective studies/or observational study.mp.

EMBASE

  1. 1.

    exp bone/or exp bone demineralization/or exp bone mineralization/or exp bone density/or exp fracture/or exp bone fragility/or exp osteoporosis/or exp fragility fracture/or exp bone mass/or bone metabolism/or exp bone mineral/or exp bone remodeling/or exp bone regeneration/or exp bone turnover/or exp osteoporosis/or exp postmenopause osteoporosis/or exp primary osteoporosis/or exp secondary osteoporosis/or exp bone regeneration/or exp bone remodeling/or exp bone density/or exp bone turnover/or exp bone/or exp ossification/or (bone adj2 turnover).ti,ab. or (bone adj2 marker*).ti,ab. or (bone adj2 biomarker*).ti,ab. or (bone adj2 formation).ti,ab.

  2. 2.

    fruit/or vegetable/or (fruit* and vegetable*).mp. or fruit*.mp. or vegetable*.mp. or (fruit* adj2 vegetable*).ti,ab.

  3. 3.

    exp clinical study/or exp intervention study/or exp longitudinal study/or exp prospective study/or exp retrospective study/or exp case control study/or exp hospital based case control study/or exp population based case control study/or exp clinical trial/or exp multicenter study/or exp phase 1 clinical trial/or exp phase 2 clinical trial/or exp phase 3 clinical trial/or exp phase 4 clinical trial/or exp controlled clinical trial/or exp randomized controlled trial/or ct.fs. or clinical trial/or phase 1 clinical trial/or phase 2 clinical trial/or phase 3 clinical trial/or phase 4 clinical trial/or controlled clinical trial/or randomized controlled trial/or multicenter study/or meta analysis/or (random: or (doubl: adj2 dummy) or ((Singl: or double: or trebl:) adj25 (blind: or mask:)) or RCT or RCTs or (control: adj25 trial:) or multicent: or placebo: or metaanalysis: or (meta adj5 analys:) or observational stud:).ti,ab.

  4. 4.

    1 and 3 and 2

CAB

  1. 1.

    exp fruit/or fruits/or exp vegetables/or fruit*.mp. or vegetable*.mp. or (fruit* and vegetable*).mp. or (fruit* adj2 vegetable*).ti,ab.

  2. 2.

    clinical trials/or (random: or (doubl: adj2 dummy) or ((Singl: or double: or trebl:) adj25 (blind: or mask:)) or RCT or RCTs or (control: adj25 trial:) or multicent: or placebo: or metaanalysis: or (meta adj5 analys:) or sham or effectiveness or efficacy or compar:).ti,ab. or exp trials/or exp randomized controlled trials/or exp clinical trials/or exp trials/or exp randomized controlled trials/or exp epidemiological surveys/or (observational study or case–control study or cohort sutdy or cross-sectional study).mp.

  3. 3.

    osteoporosis/or osteoporosis, postmenopausal/or exp bone formation/or exp bone resorption/or exp bones/or exp bone mineralization/or exp bone density/or exp bone fractures/or exp demineralization/or (bone adj2 turnover).ti,ab. or (bone adj2 marker*).ti,ab. or (bone adj2 biomarker*).ti,ab. or (bone adj2 formation).ti,ab.

  4. 4.

    1 and 3 and 2

PUBMED

(“Bone Density”[Mesh] OR (“Biological Markers”[Mesh] AND “Bone and Bones”[Mesh]) OR “Bone Remodeling”[Mesh] OR “Bone Resorption”[Mesh] OR “bone formation”[All Fields] OR “Bone turnover”[All Fields] OR “bone metabolism”[All Fields] OR “bone and bones”[MeSH Terms] OR “Fractures, Bone”[Mesh] OR “Osteoporosis”[Mesh] OR “Osteoporosis, Postmenopausal”[Mesh]) AND (“fruit”[MeSH Terms] OR “vegetables”[MeSH Terms] OR “fruit”[All Fields] OR “fruits”[All Fields] OR “vegetables”[All Fields] OR “vegetable”[All Fields]) AND (“Epidemiologic Methods”[Mesh] OR “Epidemiologic Study Characteristics as Topic”[Mesh] OR “Clinical Trials as Topic”[Mesh])

Appendix B

Table 5 Risk of bias for observational studies—developed by authors
Table 6 Risk of bias for intervention trials (modified Cochrane Collaboration's tool)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamidi, M., Boucher, B.A., Cheung, A.M. et al. Fruit and vegetable intake and bone health in women aged 45 years and over: a systematic review. Osteoporos Int 22, 1681–1693 (2011). https://doi.org/10.1007/s00198-010-1510-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-010-1510-0

Keywords

Navigation